The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Dalakas et al., N Engl J Med 329(27):1993-2000 December 30, 1993.

Correspondence
PreviousPrevious
Volume 330:1392-1393 May 12, 1994 Number 19
NextNext

Intravenous Immune Globulin for Dermatomyositis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Dalakas, M. C.
-Related Article
by Dalakas, M. C.
To the Editor: The recent report by Dalakas et al. (Dec. 30 issue)1 on the treatment of dermatomyositis with intravenous immune globulin states, "In five patients who had a major improvement after the third infusion, we performed another open-muscle biopsy." Yet the description of the study design indicates that "the code was not broken until all the patients completed the study and a second muscle biopsy was performed." Where are the results of the other biopsies?

This information is critical if the reader is to judge whether the conclusion that treatment with immune globulin leads to "marked improvement or resolution . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.